Ancient cupping technique tested for back pain relief
NCT ID NCT05792358
First seen Jun 27, 2026 · Last updated Sep 21, 2026 · Updated 1 time
Summary
This study tested whether wet cupping therapy, an ancient practice where small cuts are made on the skin and cups are used to draw out a small amount of blood, can help people with ankylosing spondylitis, a type of arthritis that mainly affects the spine. Half of the 100 participants received wet cupping plus their usual medications, while the other half only took their usual medications. The researchers measured changes in physical function, disease activity, and pain levels to see if the cupping therapy provided extra benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
109 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18-65 years * Confirmed diagnosis of ankylosing spondylitis (AS) according to the modified New York criteria or the ASAS classification criteria for axial spondyloarthritis * Active disease at enrolment, confirmed by a PM\&R specialist * Written informed consent and compliance with the study protocol Exclusion Criteria: * Having received WCT within the previous 3 months * Contraindications to WCT (hemoglobin \<9.5 g/dL, known bleeding or coagulation disorders, anticoagulant use or antiplatelet therapy other than aspirin \<100 mg, INR \>1.5, etc.) * Pregnancy or breastfeeding * Severe uncontrolled comorbidities (e.g., advanced cardiovascular disease, uncontrolled diabetes, active malignancy, severe psychiatric illness) * Any change in AS medication during the study period * Failure to complete either baseline or follow-up visits
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ankylosing spondylitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karabuk University
Karabük, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can taekwondo kicks ease ankylosing spondylitis?
- Do rheumatic diseases quietly damage the Eye's oil glands?
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could a simple protein test unlock the secrets of joint disease?
- Can a biologic drug safely tame Back-Joint inflammation? a Real-World trial investigates
- New antibody aims to calm ankylosing spondylitis